RATIONAL USE OF MEDICINES AMONGST ELDERLY DIABETIC PATIENTS IN A TERTIARY HOSPITAL IN SOUTHERN NIGERIA
DOI:
https://doi.org/10.46881/ajsn.v6i0.150Keywords:
Medicine, rational, prescribing pattern, elderly, type 2 diabetes, patientsAbstract
International Diabetes Foundation puts Nigeria's national diabetes prevalence rate at 3.9% in year 2013. Number of drugs per patient is the main factor associated with adverse reactions among elderly patients. Objective was to evaluate prescription pattern for elderly diabetic patients. This was descriptive prospective study of 150 case files of older patients diagnosed with type 2 diabetes and receiving treatment in the endocrinology clinic of Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State. Data collected included socio-demographic characteristics and pattern of prescribed medications. Data were analyzed with SPSS version 16. P 0.05 was considered significant. Mean age of the group was 65.8±10.0 years. Metformin was the most frequently prescribed (81.3%) and in combination of other antidiabetics, the highest being that with Metformin+Pioglitazone+ Glimepiride (18%). The most commonly prescribed anti hypertensives was lisinopril/Ramipril (50.0%). Mean number of drugs per prescription was 6.0. Patients mostly encountered a range of 5-7 drugs per prescription (63.3%). Drugs prescribed in generics and from essential drug list were significantly lower than the recommended WHO values (p >0.05). The findings indicate that the prescribing pattern could be said to be in compliant with our treatment guidelines although not in line with WHO's recommendations.References
Adibe, M. O., Aguwa, C. N., Ukwe, C. V., Okonta, J.M. & Udeogaranya, P.O. (2009). Outpatient utilization of anti-diabetic drugs in the South Eastern Nigeria. International Journal of Drug Development and Research. 1(1):27-36.
Akinjinmi, A. A., Adeyooye, O. A., Akingbade, O. A. & Okerentugba, P.O. (2014). Prevalence of Diabetes mellitus in Abeokuta, Ogun state, Nigeria. Researcher. 6 (2):73-75.
Akunne, O. O. & Adedapo, A. D. A. (2013). Comparative assessment of prescription quality among hypertensive patients in South-West Nigeria. International Journal of Pharmacy and Pharmacology. 32 (6): 094-098.
Alebiosu C. O.(2004)Antidiabetic / Antihypertensive prescription profile in OSUTH, Sagamu and environment. Nigerian Journal of Clinical Practice. 7(1):15-20.
Aminu, C., AbdulGafar, O., Jimoh, A. A. & Sabir, Z. S. (2011). Pattern of Antidiabetic Drugs Use in a Diabetic Outpatient Clinic of a Tertiary Health Institution in Sokoto. Journal of Medical Sciences.11:241-245.
Arije, A., Kuti, M., Fasanmade, A., Akinlade, K., Ashaye, A., Obajimi, M. & Adeleye, J. (2007). Control of hypertension in Nigerians with Diabetes Mellitus: A report of the Ibadan Diabetic / Kidney Disease Study Group. International Journal of Diabetes & Metabolism. 15:82-86.
Budnitz, D. S., Lovegrove, M. C., Shehab, N. & Richards, C. L. (2011;). Emergency hospitalizations for adverse drug events in older Americans. New England Journal of Medicine 365:2002.
Cho, S., Lau, S. W., Tandon, V., Kumi, & K., Pfuma, E. (2011). Abernethy DR. Geriatric drug evaluation: where are we now and where should we be in the future? Archive of Internal Medicine. 171(10):937.
Enwere, O. O., Salako, B. L. & Falade, C. O. (2006). Prescription and Cost Consideration at a Diabetic Clinic in Ibadan, Nigeria: A Report. Annals of Ibadan Postgraduate Medicine. 4 (2):35-39
Eze, U.I.H. & Ojieabu, W.A.(2010). Pattern of Prescriptions among Elderly Diabetic- Hypertensive Patients in a Nigerian Teaching Hospital. Africa Journal of Biomedical. Research. 13(3):169-173.
Eze, U. I. H., Odunayo, O. O. (2010). Evaluation of drug use among diabetic hypertensive patients in a teaching hospital. International Journal of Drug Development and Research. 2 (4):703-710. International Diabetes Federation. (2013). IDF Diabetes Atlas, Switzerland: (6th ed).
Isah, A. O., Ross-Degnan, D., Quick, J., Laing, R. & Mabadeje, A. F. B. 2008). The development of standard values for the WHO drug use prescribing indicators. INRUD – Nigeia1. Support Group2: DAP WHO 3. International conference in improving use of medicines. (ICIUM).
Nigeria Standard Treatment Guidelines 2008. Federal Ministry of Health, Nigeria.
Olurishe, C. O., Steven, S. Gyang., Temidayo, O. Olurishe. & Titus, T. Shekarau. (2012). Drug Utilization Review of Anti-Diabetic Medications and Therapeutic outcome in type 2 Diabetes in a Tertiary Hospital in Northern Nigeria. West African Journal of Pharmacy. 23(2):58-64.
Punam, S., Dhwani, K. (2010).Prescribing Trends Of Antidiabetics In Diabetic Patients And Hypertensive Diabetic Patients In An Urban Secondary Care Hospital. International Journal of Pharmaceutical and Biological Archives. 1(2):249-255.
Shivashankar, V., Sriram, S., Rajalingam, B., Manjula, Devi. A S., Chitra, B.& Vidhya, D. (2012). Study on Impact of Pharmacist Intervention with Type 2 Diabetic Patients. Pharmacie Globale (International Journal of Comprehensive Pharmacy). 11(9):1-3.
The Heart Outcomes Prevention Evaluation Study Investigators. (2000). Effects of an Angiotensin- converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in high-risk patients. New England Journal of Medicine. 342:145-153.
World Health Organization Action Programme on Essential Drugs. (1993). How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva, World Health Organization WHO/DAP/93.1.
World Health Organization (2009). Definition of an old or older person. Health statistics and health information systems. (World Health Survey). WHO.
World Health Organization (2010). Global Status report on non-communicable diseases (2011). Geneva, WHO: 176.
